Ovarian cancer classification: Difference between revisions

Jump to navigation Jump to search
Line 65: Line 65:
* extremely rare
* extremely rare
|-
|-
 
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Undifferentiated carcinoma of the ovary
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* ~4% of all ovarian tumor
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="15;" | Germ cell ovarian tumor (~20%)
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Ovarian teratoma: commonest primary benign tumour of ovary
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* Immature ovarian teratoma
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* Mature ovarian (cystic) teratoma
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* Specialised teratomas of the ovary
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* Struma ovarii tumour
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* Ovarian carcinoid tumor
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Ovarian dysgerminoma
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Ovarian yolk sac tumour
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* endodermal sinus tumour
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Ovarian embryonal carcinoma
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Ovarian choriocarcinoma
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* <1% of ovarian tumor
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Pure primary ovarian choriocarcinoma
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* extremely rare
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Malignant mixed germ cell tumour of the ovary
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="12;" | Sex cord / stromal ovarian tumor (8-10%)
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Ovarian fibrothecoma
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* ~5% of ovarian tumor
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Ovarian fibroma
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* ~4% of ovarian tumor
|-





Revision as of 16:57, 29 July 2019

https://https://www.youtube.com/watch?v=h8WqX5VQP88%7C350}}

Ovarian cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classifications

Pathophysiology

Causes of Ovarian cancer

Differentiating Ovarian cancer from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Staging

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ovarian cancer classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ovarian cancer classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ovarian cancer classification

CDC on Ovarian cancer classification

Ovarian cancer classification in the news

Blogs on Ovarian cancer classification

Directions to Hospitals Treating Ovarian cancer

Risk calculators and risk factors for Ovarian cancer classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.

Overview

Ovarian cancer is classified according to the histology of the tumor, obtained in a pathology report. Based on the classification, the management of ovarian cancer is directed and determined. The main four types of ovarian cancer are Surface epithelial-stromal tumour, Sex cord-stromal tumor, Germ cell tumor, and Mixed tumors.

Classification

Ovarian cancer Types Ovarian cancer subtypes
Surface epithelial-stromal tumour Ovarian serous tumor
  • Ovarian borderline serous cystadenoma: ~15% of serous tumor
  • Ovarian serous cystadenocarcinoma: ~25% of serous tumor; commonest malignant ovarian tumour
Ovarian mucinous tumor
  • Ovarian mucinous cystadenoma: ~80% of mucinous tumor
  • Ovarian borderline mucinous cystadenoma: 10-15% of mucinous tumor
  • Ovarian mucinous cystadenocarcinoma: ~5-10% of serous tumor
Ovarian endometrioid tumour
  • 8-15% of all ovarian tumor
Brenner tumour
  • ~2.5% of ovarian epithelial neoplasms
Squamous cell carcinoma of the ovary
  • ~5% of ovarian cancer
Ovarian cystadenofibroma / ovarian adenofibroma
  • can be serous, mucinous, endometrioid, clear cell or mixed
Ovarian cystadenocarcinofibroma
  • extremely rare
Undifferentiated carcinoma of the ovary
  • ~4% of all ovarian tumor
Germ cell ovarian tumor (~20%) Ovarian teratoma: commonest primary benign tumour of ovary
  • Immature ovarian teratoma
  • Mature ovarian (cystic) teratoma
  • Specialised teratomas of the ovary
  • Struma ovarii tumour
  • Ovarian carcinoid tumor
Ovarian dysgerminoma
Ovarian yolk sac tumour
  • endodermal sinus tumour
Ovarian embryonal carcinoma
Ovarian choriocarcinoma
  • <1% of ovarian tumor
Pure primary ovarian choriocarcinoma
  • extremely rare
Malignant mixed germ cell tumour of the ovary
Sex cord / stromal ovarian tumor (8-10%) Ovarian fibrothecoma
  • ~5% of ovarian tumor
Ovarian fibroma
  • ~4% of ovarian tumor


Ovarian cancer Types Ovarian cancer subtypes Ovarian cancer sub- subtypes Characterestics
Surface epithelial-stromal tumour Ovarian serous tumor Ovarian serous cystadenoma ~60% of serous tumor
Ovarian borderline serous cystadenoma ~15% of serous tumor
Ovarian serous cystadenocarcinoma ~25% of serous tumor; commonest malignant ovarian tumour
Ovarian mucinous tumor Ovarian mucinous cystadenoma ~80% of mucinous tumor
Ovarian borderline mucinous cystadenoma 10-15% of mucinous tumor
Ovarian mucinous cystadenocarcinoma ~5-10% of serous tumor
Ovarian endometrioid tumour 8-15% of all ovarian tumor
Brenner tumour ~2.5% of ovarian epithelial neoplasms
Squamous cell carcinoma of the ovary ~5% of ovarian cancer
Ovarian cystadenofibroma / ovarian adenofibroma can be serous, mucinous, endometrioid, clear cell or mixed
Ovarian cystadenocarcinofibroma: extremely rare
Undifferentiated carcinoma of the ovary: ~4% of all ovarian tumor:
Undifferentiated carcinoma of the ovary: ~4% of all ovarian tumor:
Germ cell ovarian tumor (~20%) Ovarian teratoma: commonest primary benign tumour of ovary Mature ovarian (cystic) teratoma
Immature ovarian teratoma
Specialised teratomas of the ovary
Struma ovarii tumour
Ovarian carcinoid tumor
Ovarian dysgerminoma
Ovarian yolk sac tumour: endodermal sinus tumour
Ovarian embryonal carcinoma
Ovarian choriocarcinoma: <1% of ovarian tumor
Pure primary ovarian choriocarcinoma: extremely rare
Malignant mixed germ cell tumour of the ovary
Sex cord / stromal ovarian tumor (8-10%) Ovarian fibrothecoma ~5% of ovarian tumor
Ovarian fibroma ~4% of ovarian tumor
Sclerosing stromal tumour of the ovary: rare
Ovarian Sertoli-Leydig cell tumour - ovarian androblastoma: ~0.5% of ovarian tumor
Granulosa cell tumour of ovary: commonest malignant sex cord tumour
Juvenile granulosa cell tumour of ovary
Adult granulosa cell tumour of ovary
Mixed
Others) Ovarian carcinosarcoma <1%
Ovarian lymphoma Primary ovarian lymphoma
Secondary involvement of the ovary with lymphoma
Metastases to the ovary) Krukenburg tumour
Other metastatic lesions to ovary


Other




Ovarian cancer Types Ovarian cancer subtypes Characterestics
Surface epithelial-stromal tumour Ovarian serous tumor


  • Ovarian serous cystadenoma: ~60% of serous tumor
  • Ovarian borderline serous cystadenoma: ~15% of serous tumor
  • Ovarian serous cystadenocarcinoma: ~25% of serous tumor; commonest malignant ovarian tumour
  • Ovarian mucinous tumor: ~20% of all ovarian tumor
  • Ovarian mucinous cystadenoma: ~80% of mucinous tumor
  • Ovarian bordeline mucinous cystadenoma: 10-15% of mucinous tumor
  • Ovarian mucinous cystadenocarcinoma: 5-10% of mucinous tumor

Histology dictates many aspects of clinical treatment, management, and prognosis. [1][2][3][4]

Ovarian cancer often is primary, but can also be secondary, the result of metastasis from a primary cancer elsewhere in the body. For example, from breast cancer, or from gastrointestinal cancer (in which case the ovarian cancer is a Krukenberg cancer). Surface epithelial-stromal tumor can originate in the lining of the abdominal cavity, in which case the ovarian cancer is secondary to primary peritoneal cancer, but treatment is basically the same as for primary ovarian cancer of this type.

Cellular Classification of Ovarian tumor http://radiopaedia.org/articles/ovarian-tumours

Ovarian tumor

  • Surface epithelial stromal ovarian tumor (60-70%)
  • Ovarian serous tumor
  • Ovarian serous cystadenoma: ~60% of serous tumor
  • Ovarian borderline serous cystadenoma: ~15% of serous tumor
  • Ovarian serous cystadenocarcinoma: ~25% of serous tumor; commonest malignant ovarian tumour
  • Ovarian mucinous tumor: ~20% of all ovarian tumor
  • Ovarian mucinous cystadenoma: ~80% of mucinous tumor
  • Ovarian bordeline mucinous cystadenoma: 10-15% of mucinous tumor
  • Ovarian mucinous cystadenocarcinoma: 5-10% of mucinous tumor
  • Ovarian endometrioid tumour: 8-15% of all ovarian tumor
  • Clear cell ovarian carcinoma: ~5% of ovarian cancer
  • Brenner tumour: ~2.5% of ovarian epithelial neoplasms
  • Squamous cell carcinoma of the ovary
  • Ovarian cystadenofibroma / ovarian adenofibroma: can be serous, mucinous, endometrioid, clear cell or mixed
  • Ovarian cystadenocarcinofibroma: extremely rare
  • Undifferentiated carcinoma of the ovary: ~4% of all ovarian tumor
  • Germ cell ovarian tumor (~20%)
  • Ovarian teratoma: commonest primary benign tumour of ovary
  • Mature ovarian (cystic) teratoma
  • Immature ovarian teratoma
  • Specialised teratomas of the ovary
  • Struma ovarii tumour
  • Ovarian carcinoid tumor
  • Ovarian dysgerminoma
  • Ovarian yolk sac tumour: endodermal sinus tumour
  • Ovarian embryonal carcinoma
  • Ovarian choriocarcinoma: <1% of ovarian tumor
  • Pure primary ovarian choriocarcinoma: extremely rare
  • Malignant mixed germ cell tumour of the ovary
  • Sex cord / stromal ovarian tumor (8-10%)[5][6]
  • Ovarian fibrothecoma: ~5% of ovarian tumor
  • Ovarian fibroma: ~4% of ovarian tumor
  • Ovarian thecoma: ~1% of ovarian tumor
  • Sclerosing stromal tumour of the ovary: rare
  • Ovarian Sertoli-Leydig cell tumour - ovarian androblastoma: ~0.5% of ovarian tumor
  • Granulosa cell tumour of ovary: commonest malignant sex cord tumour
  • Juvenile granulosa cell tumour of ovary
  • Adult granulosa cell tumour of ovary
  • Mixed
  • Uncommon:
  • Ovarian carcinosarcoma <1%
  • Other
  • Ovarian lymphoma
  • Primary ovarian lymphoma
  • Secondary involvement of the ovary with lymphoma
  • Metastases to the ovary
  • Krukenburg tumour
  • Other metastatic lesions to ovary

References

  1. Heintz AP, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman WT; et al. (2001). "Carcinoma of the ovary". J Epidemiol Biostat. 6 (1): 107–38. PMID 11385772.
  2. Banks E (2001). "The epidemiology of ovarian cancer". Methods Mol Med. 39: 3–11. doi:10.1385/1-59259-071-3:3. PMID 21340753.
  3. Singer G, Oldt R, Cohen Y, Wang BG, Sidransky D, Kurman RJ; et al. (2003). "Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma". J Natl Cancer Inst. 95 (6): 484–6. doi:10.1093/jnci/95.6.484. PMID 12644542.
  4. Singer G, Stöhr R, Cope L, Dehari R, Hartmann A, Cao DF; et al. (2005). "Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation". Am J Surg Pathol. 29 (2): 218–24. PMID 15644779.
  5. Chen VW, Ruiz B, Killeen JL, Coté TR, Wu XC, Correa CN (2003). "Pathology and classification of ovarian tumors". Cancer. 97 (10 Suppl): 2631–42. doi:10.1002/cncr.11345. PMID 12733128.
  6. Young RH (2005). "Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems". Mod Pathol. 18 Suppl 2: S81–98. doi:10.1038/modpathol.3800311. PMID 15502809.


Template:WikiDoc Sources